hero-line-left hero-line-top

Bringing precision medicine to more patients

Our life sciences partners are helping us answer tough questions about complex issues in cancer care



Amgen and Syapse are creating opportunities for physicians and researchers within the Syapse Network to gain access to analytics, real-world evidence-based insights, and collaborative research opportunities. Amgen will also work with Syapse to develop real-world evidence standards to support the acceleration of therapies to market.


Pfizer and Syapse are working together to understand precision oncology treatment journeys and outcomes, and are gaining insights into molecular testing and therapy choices in the healthcare system setting.


Roche and Syapse are collaborating on methods for measuring real-world outcomes, and are exploring additional areas of collaboration with the potential to bring precision medicine and improve care for more patients.

In the news

The real-world evidence project at the FDA adds Syapse to its list of partners in a push past trial boundaries

8/15/19 - The Oncology Center of Excellence is teaming up with San Francisco-based Syapse to expand beyond electronic health records — or EHRs — in building a multi-sourced program involving data drawn from EHRs and registries, as well as molecular data from testing labs. 



Precision Medicine Goes Mainstream at Leading Health Systems

Precision medicine (or personalized medicine) has been a buzzword in the healthcare industry for many years. Depending on the audience, its…